BioStem Technologies (OTCMKTS:BSEM) Issues Earnings Results

BioStem Technologies (OTCMKTS:BSEM) posted its quarterly earnings data on Thursday. The company reported $0.03 earnings per share (EPS) for the quarter, Zacks reports.

BioStem Technologies Trading Down 11.0%

Shares of OTCMKTS:BSEM traded down $0.51 on Thursday, hitting $4.14. 81,179 shares of the company were exchanged, compared to its average volume of 66,462. BioStem Technologies has a 1-year low of $3.38 and a 1-year high of $23.25. The stock’s 50 day moving average price is $4.93 and its 200 day moving average price is $9.21. The firm has a market capitalization of $69.43 million, a P/E ratio of 3.63 and a beta of -0.44.

About BioStem Technologies

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.